World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 8 January 2018
Main ID:  ISRCTN49681405
Date of registration: 30/08/2012
Prospective Registration: No
Primary sponsor: Moorfields Eye Hospital (UK)
Public title: Evaluating femtosecond laser assisted cataract and lens surgery
Scientific title: Prospective observational study to evaluate femtosecond laser lens fragmentation, anterior capsulotomy cataract and lens extraction surgery
Date of first enrolment: 28/08/2012
Target sample size: 100
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN49681405
Study type:  Observational
Study design:  Prospective observational study (Treatment)  
Phase: 
Countries of recruitment
United Kingdom
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Julian    Stevens
Address:  81 Britannia Walk N1 7RH London United Kingdom
Telephone: +44 20 7251 4835/4836
Email: info@julianstevens.co.uk
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Any subject planned to undergo femtosecond laser assisted lens surgery. These subjects will already meet these criteria:
1. Subjects must be adults (>16 years), undergoing refractive lens or cataract surgery
2. Subjects must provide informed consent, have signed the written informed consent form, and been given a copy
3. Subjects must have a calculated average corneal power after of = 50.00 D in the eye to be implanted
4. Subjects must have a pharmacologically dilated pupil >6.0 mm, in the eye to be implanted
5. The central anterior chamber depth must be >2.0 mm (Pentacam)
6. Subjects must be willing and able to return for scheduled follow up examinations for 3 months after surgery

Exclusion criteria: 1. Subjects with subluxated crystalline lens
2. Subjects with endothelial dystrophy, guttata, in the eye to be implanted
3. Subjects with keratoconus (or keratoconus suspect) in the eye to be implanted or K>50 D
4. Subjects with distorted or unclear corneal mires on topography maps of the eye to be implanted
5. Subjects with a history of Herpes zoster or Herpes simplex keratitis.
6. The central anterior chamber depth <2.0 mm (Pentacam)
7. Tremor with head titubation
8. Subjects who are participating in any other ophthalmic drug or device clinical trial during the time of this clinical investigation


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Cataract, refractive error
Eye Diseases
Other cataract
Intervention(s)
This is an observational study of surgery outcomes.
Primary Outcome(s)
To record any complications or adverse events
Secondary Outcome(s)
To describe the ability of the intraocular femtosecond laser to successfully perform an anterior
capsulotomy and phakofragmentation during cataract/lens surgery.
Secondary ID(s)
Protocol version 4.3
Source(s) of Monetary Support
Investigator initiated and funded
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history